Therapeutics: Glucose-dependent insulinotropic polypeptide (GIP) receptor; glucagon-like peptide-1 receptor (GLP-1R; GLP1R); glucagon receptor (GCGR)

Mouse studies suggest a monomeric peptide agonist of GIP receptor, GLP1R and GCGR could help treat obesity and diabetes. In a mouse model of diet-induced obesity, the triple agonist decreased body wei...